Ads
related to: Latest Treatment Copd
Search results
Prostate cancer isn’t always deadly — but here’s when it can be
NY Post via Yahoo News· 6 days agoThose living with cancer can be more susceptible to other health issues, or may already have another...
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
Casper Star-Tribune· 2 days agoAmgen (NASDAQ:AMGN) today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD
Joe Biden Released His 2023 Earnings. Here’s What It Means For His Net Worth
Forbes· 19 hours agoThe president’s salary is well above that of an average American. But is it enough to drive up his...
BTIG starts Theravance Biopharma stock on BUY, cites 'pivotal' data for ampreloxetine
Investing.com· 7 days agoOn Friday, Theravance Biopharma (NASDAQ: TBPH ) stock received a Buy rating from BTIG, with a new...
New heart disease calculator could save lives by identifying high-risk patients missed by current...
Medical Xpress· 10 hours agoCollaborative research, led from the University of Oxford and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk ...
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides...
Investing.com· 6 days agoASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides...
BTIG Research Predicts Over 118% Rally for These 3 Stocks
InvestorPlace· 3 days agoThe stock market may have pulled back a bit from the all-time high reached late last month but the S&P 500 remains 7.4% higher in 2024. Technology stocks continue to be top ...
State’s Award-Winning Hospitals
New Jersey Business Magazine· 7 days agoDoctors at Englewood Hospital and Medical Center perform anuerysm surgery. The hospital received a Safety Grade of “A” for the fall 2016 period from the...
Cancer sufferer who met Kate says his ‘heart goes out to her’ after diagnosis
Press Association News via AOL· 4 days agoNow I think she just wants to get on and do her treatment,” he added. Mr Roberts believes that the...
Brokerages Set Apogee Therapeutics, Inc. (NASDAQ:APGE) Price Target at $71.83
ETF DAILY NEWS· 7 days agoShares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been given a consensus recommendation of “Buy” by the seven ratings firms that are currently covering the stock, MarketBeat ...
